专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20100311749A1 4-BENZOYL-1-SUBSTITUTED-PIPERAZIN-2-ONE DERIVATIVES AS P2X7 MODULATORS 审中-公开
标题翻译：作为P2X7调节剂的4-苯甲酰基-1-取代的哌嗪-2-酮衍生物
公开(公告)号：US20100311749A1
公开(公告)日：2010-12-09
申请号：US12739462
申请日：2008-10-24
申请人： Laura Jane Chambers , Katharine Laura Collis , David Kenneth Dean , Jorge Munoz-Muriedas , Jon Graham Anthony Steadman , Daryl Simon Walter
发明人： Laura Jane Chambers , Katharine Laura Collis , David Kenneth Dean , Jorge Munoz-Muriedas , Jon Graham Anthony Steadman , Daryl Simon Walter
IPC分类号： A61K31/5377 , C07D241/08 , A61K31/495 , C07D413/10 , C07D401/06 , A61K31/496 , C07D405/06 , C07D403/10 , A61P29/00 , A61P25/28 , A61P19/02
CPC分类号： C07D241/08 , C07D401/06 , C07D401/10 , C07D403/10 , C07D407/06
摘要： The invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof: wherein: A is C1-6alkyl, C3-6cycloalkyl, —CH2—R6, —CHMe-R7, —CMe2-R7, or optionally substituted aryl; wherein, when A is optionally substituted aryl, said aryl group is optionally substituted with 1 to 3 substituents, which may be the same or different, selected from the group consisting of halogen, C1-6alkyl, —CF3, C1-4alkoxy, C1fluoroalkoxy, cyano, NR8R9, and pyridyl wherein the pyridyl is optionally substituted by one methyl; R1 is chlorine, fluorine, —CF3, cyano or C1-6alkyl; R2, R3 and R5 independently are hydrogen, fluorine, chlorine, —CF3, cyano or C1-6alkyl, such that at least one of R2, R3 and R5 is other than hydrogen; R4 is hydrogen. These compounds and salts are thought to be P2X7 receptor antagonists. The invention also provides for the treatment of pain, inflammation, rheumatoid arthritis, osteoarthritis, or a neurodegenerative disease.
摘要翻译：本发明提供式（I）化合物或其药学上可接受的盐：其中：A为C 1-6烷基，C 3-6环烷基，-CH 2 -R 6，-CHMe-R 7，-CMe 2 -R 7或任选取代的芳基; 其中当A是任选取代的芳基时，所述芳基任选地被1至3个选自卤素，C 1-6烷基，-CF 3，C 1-4烷氧基，C 1-6烷氧基，氰基，NR8R9和吡啶基，其中吡啶基任选被一个甲基取代; R1是氯，氟，-CF3，氰基或C1-6烷基; R2，R3和R5独立地是氢，氟，氯，-CF3，氰基或C1-6烷基，使得R2，R3和R5中的至少一个不是氢; R4是氢。这些化合物和盐被认为是P2X7受体拮抗剂。本发明还提供治疗疼痛，炎症，类风湿性关节炎，骨关节炎或神经变性疾病。

2. 发明授权

US08501946B2 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyrazine derivatives as P2X7 modulators 有权
标题翻译： 5,6,7,8-四氢[1,2,4]三唑并[4,3-a]吡嗪衍生物，为P2X7调节剂
公开(公告)号：US08501946B2
公开(公告)日：2013-08-06
申请号：US13266592
申请日：2010-04-28
申请人： David Kenneth Dean , Jorge Munoz-Muriedas , Mairi Sime , Jon Graham Anthony Steadman , Rachel Elizabeth Anne Thewlis , Giancarlo Trani , Daryl Simon Walter
发明人： David Kenneth Dean , Jorge Munoz-Muriedas , Mairi Sime , Jon Graham Anthony Steadman , Rachel Elizabeth Anne Thewlis , Giancarlo Trani , Daryl Simon Walter
IPC分类号： C07D495/00
CPC分类号： C07D487/04
摘要： The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof: wherein A is hydrogen, C1-4alkyl, C3-6cycloalkyl, C1-3alkoxy, C1-3alkoxy C1-4alkyl, C1-2fluoroalkyl, halogen, NR6R7, optionally substituted heteroaryl (Het), or optionally substituted phenyl, and R1, R2, R3, R4, R5, R6 and R7 are as defined in the description. The compounds or salts are thought to modulate P2X7 receptor function and to be capable of antagonizing the effects of ATP at the P2X7 receptor. The invention also provides the use of the compound or salt in the treatment or prophylaxis of, for example, inflammatory pain, neuropathic pain, visceral pain, rheumatoid arthritis, osteoarthritis or neurodegenerative disorders.
摘要翻译：本发明提供式（I）化合物或其药学上可接受的盐：其中A为氢，C 1-4烷基，C 3-6环烷基，C 1-3烷氧基，C 1-3烷氧基C 1-4烷基，C 1-2 - 氟烷基，卤素，NR 6 R 7，任选取代的杂芳基（Het）或任选取代的苯基，并且R 1，R 2，R 3，R 4，R 5，R 6和R 7如说明书中所定义。认为化合物或盐可以调节P2X7受体功能，并能够拮抗ATP在P2X7受体上的作用。本发明还提供了化合物或盐在治疗或预防例如炎性疼痛，神经性疼痛，内脏痛，类风湿性关节炎，骨关节炎或神经变性疾病中的用途。

3. 发明申请

US20120172366A1 5,6,7,8-TETRAHYDROIMIDAZO[1,2-A]PYRAZINE DERIVATIVES AS P2X7 MODULATORS 有权
标题翻译：作为P2X7调节剂的5,6,7,8-四氢吡啶并[1,2-A]吡嗪衍生物
公开(公告)号：US20120172366A1
公开(公告)日：2012-07-05
申请号：US13266557
申请日：2010-04-28
申请人： David Kenneth Dean , Jorge Munoz-Muriedas , Mairi Sime , Jon Graham Anthony Steadman , Rachel Elizabeth Anne Thewlis , Giancarlo Trani , Ian David Wall , Daryl Simon Walter
发明人： David Kenneth Dean , Jorge Munoz-Muriedas , Mairi Sime , Jon Graham Anthony Steadman , Rachel Elizabeth Anne Thewlis , Giancarlo Trani , Ian David Wall , Daryl Simon Walter
IPC分类号： A61K31/4985 , A61P29/00 , A61P25/16 , A61P25/08 , A61P25/14 , C07D487/04 , A61P25/28
CPC分类号： C07D487/04
摘要： The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof: wherein A is hydrogen, C1-4alkyl, C3-6cycloalkyl, C1-3alkoxy, C1-3alkoxy C1-4alkyl, C1-2fluoroalkyl, halogen, NR6R7, optionally substituted heteroaryl, or optionally substituted phenyl, and R1, R2, R3, R4, R5, R6 and R7 are as defined in the description.The compounds or salts are thought to modulate P2X7 receptor function and to be capable of antagonizing the effects of ATP at the P2X7 receptor. The invention also provides the use of the compound or salt in the treatment or prophylaxis of, for example, inflammatory pain, neuropathic pain, visceral pain, rheumatoid arthritis or osteoarthritis or neurodegenerative disorders.
摘要翻译：本发明提供式（I）化合物或其药学上可接受的盐：其中A为氢，C 1-4烷基，C 3-6环烷基，C 1-3烷氧基，C 1-3烷氧基C 1-4烷基，C 1-2 - 氟烷基，卤素，NR 6 R 7，任选取代的杂芳基或任选取代的苯基，并且R 1，R 2，R 3，R 4，R 5，R 6和R 7如说明书中所定义。认为化合物或盐可以调节P2X7受体功能，并能够拮抗ATP在P2X7受体上的作用。本发明还提供了化合物或盐在治疗或预防例如炎性疼痛，神经性疼痛，内脏痛，类风湿性关节炎或骨关节炎或神经变性疾病中的用途。

4. 发明申请

US20120157436A1 5,6,7,8-TETRAHYDRO[1,2,4]TRIAZOLO[4,3-a]PYRAZINE DERIVATIVES AS P2X7 MODULATORS 有权
标题翻译： 5,6,7,8-四氢[1,2,4]三唑[4,3-a]吡嗪衍生物作为P2X7调节剂
公开(公告)号：US20120157436A1
公开(公告)日：2012-06-21
申请号：US13266592
申请日：2010-04-28
申请人： David Kenneth Dean , Jorge Munoz-Muriedas , Mairi Sime , Jon Graham Anthony Steadman , Rachel Elizabeth Anne Thewlis , Giancarlo Trani , Daryl Simon Walter
发明人： David Kenneth Dean , Jorge Munoz-Muriedas , Mairi Sime , Jon Graham Anthony Steadman , Rachel Elizabeth Anne Thewlis , Giancarlo Trani , Daryl Simon Walter
IPC分类号： A61K31/4985 , A61K31/506 , A61K31/5377 , A61P25/14 , A61P29/00 , A61P25/28 , A61P25/08 , A61P25/16 , C07D487/04 , A61K31/501
CPC分类号： C07D487/04
摘要： The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof: wherein A is hydrogen, C1-4alkyl, C3-6cycloalkyl, C1-3alkoxy, C1-3alkoxy C1-4alkyl, C1-2-fluoroalkyl, halogen, NR6R7, optionally substituted heteroaryl, or optionally substituted phenyl, and R1, R2, R3, R4, R5, R6 and R7 are as defined in the description. The compounds or salts are thought to modulate P2X7 receptor function and to be capable of antagonizing the effects of ATP at the P2X7 receptor. The invention also provides the use of the compound or salt in the treatment or prophylaxis of, for example, inflammatory pain, neuropathic pain, visceral pain, rheumatoid arthritis, osteoarthritis or neurodegenerative disorders.
摘要翻译：本发明提供式（I）化合物或其药学上可接受的盐：其中A为氢，C 1-4烷基，C 3-6环烷基，C 1-3烷氧基，C 1-3烷氧基C 1-4烷基，C 1-2 - 氟烷基，卤素， NR 6 R 7，任选取代的杂芳基或任选取代的苯基，并且R 1，R 2，R 3，R 4，R 5，R 6和R 7如说明书中所定义。认为化合物或盐可以调节P2X7受体功能，并能够拮抗ATP在P2X7受体上的作用。本发明还提供了化合物或盐在治疗或预防例如炎性疼痛，神经性疼痛，内脏痛，类风湿性关节炎，骨关节炎或神经变性疾病中的用途。

5. 发明授权

US08513248B2 5,6,7,8-tetrahydroimidazo[1,2-A]pyrazine derivatives as P2X7 modulators 有权
标题翻译： 5,6,7,8-四氢咪唑并[1,2-A]吡嗪衍生物作为P2X7调节剂
公开(公告)号：US08513248B2
公开(公告)日：2013-08-20
申请号：US13266557
申请日：2010-04-28
申请人： David Kenneth Dean , Jorge Munoz-Muriedas , Mairi Sime , Jon Graham Anthony Steadman , Rachel Elizabeth Anne Thewlis , Giancarlo Trani , Ian David Wall , Daryl Simon Walter
发明人： David Kenneth Dean , Jorge Munoz-Muriedas , Mairi Sime , Jon Graham Anthony Steadman , Rachel Elizabeth Anne Thewlis , Giancarlo Trani , Ian David Wall , Daryl Simon Walter
IPC分类号： A61K31/495
CPC分类号： C07D487/04
摘要： The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof: wherein A is hydrogen, C1-4alkyl, C3-6cycloalkyl, C1-3alkoxy, C1-3alkoxy C1-4alkyl, C1-2fluoroalkyl, halogen, NR6R7, optionally substituted heteroaryl (Het), or optionally substituted phenyl, and R1, R2, R3, R4, R5, R6 and R7 are as defined in the description. The compounds or salts are thought to modulate P2X7 receptor function and to be capable of antagonizing the effects of ATP at the P2X7 receptor. The invention also provides the use of the compound or salt in the treatment or prophylaxis of, for example, inflammatory pain, neuropathic pain, visceral pain, rheumatoid arthritis or osteoarthritis or neurodegenerative disorders.
摘要翻译：本发明提供式（I）化合物或其药学上可接受的盐：其中A为氢，C 1-4烷基，C 3-6环烷基，C 1-3烷氧基，C 1-3烷氧基C 1-4烷基，C 1-2 - 氟烷基，卤素，NR 6 R 7，任选取代的杂芳基（Het）或任选取代的苯基，并且R 1，R 2，R 3，R 4，R 5，R 6和R 7如说明书中所定义。认为化合物或盐可以调节P2X7受体功能，并能够拮抗ATP在P2X7受体上的作用。本发明还提供了化合物或盐在治疗或预防例如炎性疼痛，神经性疼痛，内脏痛，类风湿性关节炎或骨关节炎或神经变性疾病中的用途。

6. 发明授权

US07932282B2 Imidazolidine carboxamide derivatives as P2X7 modulators 失效
标题翻译：咪唑烷羧酰胺衍生物作为P2X7调节剂
公开(公告)号：US07932282B2
公开(公告)日：2011-04-26
申请号：US12594381
申请日：2008-04-02
申请人： Paul John Beswick , David Kenneth Dean , Robert James Gleave , Andrew Peter Moses , Daryl Simon Walter
发明人： Paul John Beswick , David Kenneth Dean , Robert James Gleave , Andrew Peter Moses , Daryl Simon Walter
IPC分类号： A61K31/4164 , C07D233/02
CPC分类号： C07D233/36 , C07D401/04 , C07D401/06 , C07D403/04
摘要： The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof: The compounds or salts modulate P2X7 receptor function and are capable of antagonizing the effects of ATP at the P2X7 receptor (P2X7 receptor antagonists). The invention also provides the use of such compounds or salts, or pharmaceutical compositions thereof, in the treatment or prevention of disorders/diseases mediated by the P2X7 receptor, for example pain, inflammation or a neurodegenerative disease, in particular pain such as inflammatory pain, neuropathic pain or visceral pain.
摘要翻译：本发明涉及式（I）化合物或其药学上可接受的盐：该化合物或盐调节P2X7受体功能并能够拮抗ATP在P2X7受体（P2X7受体拮抗剂）下的作用。本发明还提供了这样的化合物或其盐或其药物组合物在治疗或预防P2X7受体介导的病症/疾病中的用途，例如疼痛，炎症或神经变性疾病，特别是疼痛，例如炎性疼痛，神经性疼痛或内脏痛。

7. 发明申请

US20100075968A1 Imidazolidine Carboxamide Derivatives as P2X7 Modulators 失效
标题翻译：咪唑烷羧酰胺衍生物作为P2X7调节剂
公开(公告)号：US20100075968A1
公开(公告)日：2010-03-25
申请号：US12594381
申请日：2008-04-02
申请人： Paul John Beswick , David Kenneth Dean , Robert James Gleave , Andrew Peter Moses , Daryl Simon Walter
发明人： Paul John Beswick , David Kenneth Dean , Robert James Gleave , Andrew Peter Moses , Daryl Simon Walter
IPC分类号： A61K31/5377 , C07D233/02 , A61K31/4164 , C07D401/02 , A61K31/4439 , C07D239/02 , A61K31/506 , A61K31/454 , C07D413/02 , C07D241/10 , A61K31/497 , C07D403/02 , A61K31/501 , A61P29/00 , A61P25/00
CPC分类号： C07D233/36 , C07D401/04 , C07D401/06 , C07D403/04
摘要： The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof: The compounds or salts modulate P2X7 receptor function and are capable of antagonizing the effects of ATP at the P2X7 receptor (P2X7 receptor antagonists). The invention also provides the use of such compounds or salts, or pharmaceutical compositions thereof, in the treatment or prevention of disorders/diseases mediated by the P2X7 receptor, for example pain, inflammation or a neurodegenerative disease, in particular pain such as inflammatory pain, neuropathic pain or visceral pain.
摘要翻译：本发明涉及式（I）化合物或其药学上可接受的盐：该化合物或盐调节P2X7受体功能并且能够拮抗ATP在P2X7受体（P2X7受体拮抗剂）下的作用。本发明还提供了这样的化合物或其盐或其药物组合物在治疗或预防P2X7受体介导的病症/疾病中的用途，例如疼痛，炎症或神经变性疾病，特别是疼痛，例如炎性疼痛，神经性疼痛或内脏痛。

8. 发明申请

US20100056595A1 Pyrazole Derivatives as P2X7 Modulators 审中-公开
标题翻译：吡唑衍生物作为P2X7调节剂
公开(公告)号：US20100056595A1
公开(公告)日：2010-03-04
申请号：US12595099
申请日：2008-04-10
申请人： Paul John Beswick , David Kenneth Dean , Daryl Simon Walter
发明人： Paul John Beswick , David Kenneth Dean , Daryl Simon Walter
IPC分类号： A61K31/415 , C07D231/12 , A61P25/00
CPC分类号： C07D231/16 , C07D231/12
摘要： The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof: wherein R1 represents C1-6 alkyl or C3-6 cycloalkyl, either of which is optionally substituted with 1, 2 or 3 halogen atoms; and R2 represents hydrogen, halogen, C1-6 alkyl or C3-6 cycloalkyl; and either of said C1-6 alkyl or C3-6 cycloalkyl is optionally substituted with 1, 2 or 3 halogen atoms. The pyrazole compounds of formula (I) or salts thereof modulate P2X7 receptor function and are capable of antagonizing the effects of ATP at the P2X7 receptor (P2X7 receptor antagonists). The invention also relates to the use of such compounds or salts, or pharmaceutical compositions thereof, in the treatment or prevention of disorders/diseases mediated by the P2X7 receptor, for example pain, inflammation or a neurodegenerative disease.
摘要翻译：本发明涉及式（I）化合物或其药学上可接受的盐：其中R1表示C1-6烷基或C3-6环烷基，其任一个任选被1,2或3个卤素原子取代; 并且R 2表示氢，卤素，C 1-6烷基或C 3-6环烷基; 并且所述C 1-6烷基或C 3-6环烷基中的任一个任选被1,2或3个卤素原子取代。式（I）的吡唑化合物或其盐调节P2X7受体功能，并且能够拮抗ATP在P2X7受体（P2X7受体拮抗剂）下的作用。本发明还涉及这些化合物或其盐或其药物组合物在治疗或预防P2X7受体介导的疾病/疾病中的用途，例如疼痛，炎症或神经变性疾病。

9. 发明申请

US20090149524A1 N-(Phenylmethyl)-2-(1H-Pyrazol-4-yl) Acetamide Derivatives as P2X7 Antagonists for the Treatment of Pain, Inflammation and Neurodegeneration 审中-公开
标题翻译： N-（苯基甲基）-2-（1H-吡唑-4-基）乙酰胺衍生物作为P2X7拮抗剂用于治疗疼痛，炎症和神经退行性疾病
公开(公告)号：US20090149524A1
公开(公告)日：2009-06-11
申请号：US12303260
申请日：2007-06-05
申请人： Paul John Beswick , Laura J. Chambers , David John Davies , David Kenneth Dean , Emmanuel Hubert Demont , Susan Roomans , Daryl Simon Walter
发明人： Paul John Beswick , Laura J. Chambers , David John Davies , David Kenneth Dean , Emmanuel Hubert Demont , Susan Roomans , Daryl Simon Walter
IPC分类号： A61K31/415 , C07D231/10 , A61P25/28
CPC分类号： C07D231/12
摘要： The present invention relates to novel pyrazole derivatives of formula (I) which bind to the P2X7 receptor and are capable of interfering with the effects of ATP at the P2X7 receptor: and the use of such compounds or pharmaceutical compositions thereof in the treatment of disorders mediated by the P2X7 receptor, for example pain, inflammation and neurodegeneration.
摘要翻译：本发明涉及结合P2X7受体并能够干扰ATP在P2X7受体上的作用的式（I）的吡唑衍生物，以及这些化合物或其药物组合物在治疗疾病介导中的用途通过P2X7受体，例如疼痛，炎症和神经变性。

10. 发明授权

US07375105B2 Pyridine substituted furan derivatives as Raf kinase inhibitors 失效
标题翻译：吡啶取代的呋喃衍生物作为Raf激酶抑制剂
公开(公告)号：US07375105B2
公开(公告)日：2008-05-20
申请号：US10488650
申请日：2002-09-05
申请人： David Kenneth Dean , Andrew Kenneth Takle , David Matthew Wilson
发明人： David Kenneth Dean , Andrew Kenneth Takle , David Matthew Wilson
IPC分类号： A61K31/5377 , A61K31/4545 , A61K31/443 , C07D413/14 , C07D211/32 , C07D405/04
CPC分类号： C07D405/04 , C07D405/14
摘要： Compounds and their use as pharmaceuticals particularly as Raf kinase inhibitors for the treatment of neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine and cardiac hypertrophy. Wherein X is O, CH2 CO, S or NH, or the moiety X—R1 is hydrogen; Y1 and Y2 independently represent CH or N; Ar is a mono- or fused bicyclic aromatic or heteroaromatic group which may be optionally substituted; one of X1 and X2 is selected from O, S or NR11 and the other is CH, wherein R11 is hydrogen, C1-6alkyl, aryl or arylC1-6alkyl.
摘要翻译：化合物及其作为药物的用途，特别是用作治疗神经创伤性疾病，癌症，慢性神经变性，疼痛，偏头痛和心脏肥大的Raf激酶抑制剂。其中X是O，CH 2 CO，S或NH，或者X-R 1部分是氢; Y 1和Y 2独立地表示CH或N; Ar是可以任选取代的单或二稠合双环芳族或杂芳族基团; X 1和X 2之一选自O，S或NR 11，另一个是CH，其中R 11， / SUP>是氢，C 1-6烷基，芳基或芳基C 1-6烷基。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式